CA Patent

CA2464094C — Methods for ligand discovery

Assigned to Viracta Therapeutics Inc · Expires 2013-07-02 · 13y expired

What this patent protects

The present invention provides novel methods for ligand discovery. The inventive methods rely on a process termed "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified as exemplified by the figure.

USPTO Abstract

The present invention provides novel methods for ligand discovery. The inventive methods rely on a process termed "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified as exemplified by the figure.

Drugs covered by this patent

Patent Metadata

Patent number
CA2464094C
Jurisdiction
CA
Classification
—
Expires
2013-07-02
Drug substance claim
No
Drug product claim
No
Assignee
Viracta Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.